285 related articles for article (PubMed ID: 18202428)
1. Adjuvant chemotherapy following neoadjuvant therapy of rectal cancer: the type of neoadjuvant therapy (chemoradiotherapy or radiotherapy) may be important for selection of patients.
Fietkau R; Klautke G
J Clin Oncol; 2008 Jan; 26(3):507-8; author reply 508-9. PubMed ID: 18202428
[No Abstract] [Full Text] [Related]
2. Radiation plus chemotherapy as adjuvant therapy for rectal cancer.
Minsky BD
Best Pract Res Clin Gastroenterol; 2002 Apr; 16(2):267-82. PubMed ID: 11969238
[TBL] [Abstract][Full Text] [Related]
3. Will we ever succeed in resolving the adjuvant treatment dilemma in rectal cancer?
Petrelli NJ
J Surg Oncol; 2003 Feb; 82(2):79-83. PubMed ID: 12561061
[No Abstract] [Full Text] [Related]
4. [Downstaging after neoadjuvant therapy for rectal cancer modifies the planned original surgery].
Scutari F; Tramutola G; Morlino A; Rossi MT; Manzione L; Rosati G; Sopranzi A
G Chir; 2008; 29(6-7):277-80. PubMed ID: 18544264
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemoradiation in rectal cancer: time to start in a new direction.
Mohiuddin M; Mohiuddin MM
J Clin Oncol; 2011 Apr; 29(12):e350-1; author reply e352-3. PubMed ID: 21402612
[No Abstract] [Full Text] [Related]
6. The role of carcinoembriogenic antigen in predicting response and survival to neoadjuvant chemoradiotherapy for distal rectal cancer.
Perez RO; São Julião GP; Habr-Gama A; Kiss D; Proscurshim I; Campos FG; Gama-Rodrigues JJ; Cecconello I
Dis Colon Rectum; 2009 Jun; 52(6):1137-43. PubMed ID: 19581858
[TBL] [Abstract][Full Text] [Related]
7. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
[TBL] [Abstract][Full Text] [Related]
8. Role of neoadjuvant chemotherapy in rectal cancer: interpretation of the EXPERT study.
Glynne-Jones R; Sebag-Montefiore D
J Clin Oncol; 2006 Oct; 24(28):4664-5; author reply 4665-6. PubMed ID: 17008708
[No Abstract] [Full Text] [Related]
9. Locally advanced rectal cancer patients receiving radio-chemotherapy: a novel clinical-pathologic score correlates with global outcome.
Berardi R; Mantello G; Scartozzi M; Del Prete S; Luppi G; Martinelli R; Fumagalli M; Grillo-Ruggieri F; Bearzi I; Mandolesi A; Marmorale C; Cascinu S
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1437-43. PubMed ID: 19386440
[TBL] [Abstract][Full Text] [Related]
10. [Advantages of neoadjuvant therapy in rectal neoplasm].
Nano M; Ferronato M; Solej M; D'Amico S
G Chir; 2008 May; 29(5):197-202. PubMed ID: 18507953
[No Abstract] [Full Text] [Related]
11. [Adjuvant therapy in rectal cancer].
Lovas P; Lovasová Z
Klin Onkol; 2011; 24(2):94-100. PubMed ID: 21644363
[TBL] [Abstract][Full Text] [Related]
12. Multidisciplinary treatment of resectable rectal cancer.
Ayala DN; Russo SM; Blackstock AW
Expert Rev Gastroenterol Hepatol; 2009 Aug; 3(4):383-94. PubMed ID: 19673625
[TBL] [Abstract][Full Text] [Related]
13. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer.
Tulchinsky H; Shmueli E; Figer A; Klausner JM; Rabau M
Ann Surg Oncol; 2008 Oct; 15(10):2661-7. PubMed ID: 18389322
[TBL] [Abstract][Full Text] [Related]
14. [Neoadjuvant chemoradiation therapy for locally advanced rectal cancer].
Sato T; Ozawa H; Kisyu K; Kumamoto H; Nakamura T; Onozato W; Yamanashi T; Kokuba Y; Ihara A; Watanabe M
Gan To Kagaku Ryoho; 2007 Oct; 34(10):1553-6. PubMed ID: 17940371
[TBL] [Abstract][Full Text] [Related]
15. [New pattern of comprehensive treatment for rectal cancer: the ascendant neoadjuvant radiochemotherapy].
Wang JP
Zhonghua Wai Ke Za Zhi; 2007 Sep; 45(17):1156-9. PubMed ID: 18067704
[No Abstract] [Full Text] [Related]
16. Adjuvant management of rectal cancer: the more we learn, the less we know.
Minsky BD
J Clin Oncol; 2007 Oct; 25(28):4339-40. PubMed ID: 17906196
[No Abstract] [Full Text] [Related]
17. Developments in the use of chemoradiotherapy in rectal cancer.
Sebag-Montefiore D
Colorectal Dis; 2006 Sep; 8 Suppl 3():14-7. PubMed ID: 16813586
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients.
Capirci C; Valentini V; Cionini L; De Paoli A; Rodel C; Glynne-Jones R; Coco C; Romano M; Mantello G; Palazzi S; Mattia FO; Friso ML; Genovesi D; Vidali C; Gambacorta MA; Buffoli A; Lupattelli M; Favretto MS; La Torre G
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):99-107. PubMed ID: 18407433
[TBL] [Abstract][Full Text] [Related]
19. Assessment and management of the complete clinical response of rectal cancer to chemoradiotherapy.
Habr-Gama A
Colorectal Dis; 2006 Sep; 8 Suppl 3():21-4. PubMed ID: 16813588
[TBL] [Abstract][Full Text] [Related]
20. Complete pathologic response after preoperative rectal cancer chemoradiotherapy.
Ciccocioppo A; Stephens JH; Hewett PJ; Rieger NA
ANZ J Surg; 2009 Jun; 79(6):481-4. PubMed ID: 19566874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
